An experimental Covid-19 vaccine appears to offer strong protection in late-stage UK and South Africa studies, said manufacturer Novavax.
The UK hassecured access to 60 million doses of the vaccine, called NVX-CoV2373.
Dr. Fauci discusses how variants can affect vaccine efficacy
Bleacher Report AOL
Dr. Anthony Fauci discusses new variants of the coronavirus at a White House Covid-19 briefing and how it will affect vaccine..
